Šárka Pavlová

1.4k total citations
42 papers, 854 citations indexed

About

Šárka Pavlová is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Šárka Pavlová has authored 42 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 18 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Šárka Pavlová's work include Chronic Lymphocytic Leukemia Research (25 papers), Cancer-related Molecular Pathways (16 papers) and Lymphoma Diagnosis and Treatment (10 papers). Šárka Pavlová is often cited by papers focused on Chronic Lymphocytic Leukemia Research (25 papers), Cancer-related Molecular Pathways (16 papers) and Lymphoma Diagnosis and Treatment (10 papers). Šárka Pavlová collaborates with scholars based in Czechia, Germany and Sweden. Šárka Pavlová's co-authors include Šárka Pospı́šilová, Karla Plevová, Jana Šmardová, Yvona Brychtová, Michael Doubek, Boris Tichý, Jitka Malčíková, Jiřı́ Mayer, Martin Trbušek and Kateřina Staňo Kozubík and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Šárka Pavlová

40 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Šárka Pavlová Czechia 15 443 342 258 190 176 42 854
Simona Tavolaro Italy 16 401 0.9× 384 1.1× 141 0.5× 282 1.5× 221 1.3× 31 820
Maher Albitar United States 14 321 0.7× 287 0.8× 213 0.8× 197 1.0× 126 0.7× 48 783
Michela Frenquelli Italy 13 367 0.8× 300 0.9× 88 0.3× 173 0.9× 260 1.5× 19 720
Xiangao Huang United States 12 401 0.9× 325 1.0× 382 1.5× 311 1.6× 159 0.9× 40 873
Kathleen J. Till United Kingdom 15 434 1.0× 504 1.5× 215 0.8× 221 1.2× 329 1.9× 24 884
Larry Mansouri Sweden 19 394 0.9× 591 1.7× 170 0.7× 397 2.1× 307 1.7× 37 944
Archito T. Tamayo United States 16 631 1.4× 246 0.7× 412 1.6× 393 2.1× 413 2.3× 34 1.2k
Charis E. Teh Australia 16 428 1.0× 234 0.7× 190 0.7× 164 0.9× 404 2.3× 34 946
Anna Dolnik Germany 15 564 1.3× 190 0.6× 151 0.6× 122 0.6× 89 0.5× 39 900
Frédéric Gilles United States 12 375 0.8× 202 0.6× 300 1.2× 353 1.9× 81 0.5× 21 753

Countries citing papers authored by Šárka Pavlová

Since Specialization
Citations

This map shows the geographic impact of Šárka Pavlová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šárka Pavlová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šárka Pavlová more than expected).

Fields of papers citing papers by Šárka Pavlová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Šárka Pavlová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šárka Pavlová. The network helps show where Šárka Pavlová may publish in the future.

Co-authorship network of co-authors of Šárka Pavlová

This figure shows the co-authorship network connecting the top 25 collaborators of Šárka Pavlová. A scholar is included among the top collaborators of Šárka Pavlová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Šárka Pavlová. Šárka Pavlová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Σταματόπουλος, Κώστας, Šárka Pavlová, Othman Al‐Sawaf, et al.. (2024). Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities. HemaSphere. 8(7). e113–e113. 2 indexed citations
2.
Malčíková, Jitka, Šárka Pavlová, Panagiotis Baliakas, et al.. (2024). ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update. Leukemia. 38(7). 1455–1468. 8 indexed citations
3.
Zerkalenkova, Elena, Michael Doubek, Ekaterina A. Komech, et al.. (2022). The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 23(3). 1756–1756.
4.
Pavlová, Šárka, Beatríz González, Jana Kotašková, et al.. (2022). Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene. Epigenetics. 17(12). 1628–1635. 3 indexed citations
5.
Plevová, Karla, Šárka Pavlová, Jitka Malčíková, et al.. (2022). Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC Cancer. 22(1). 137–137. 3 indexed citations
6.
Malčíková, Jitka, Šárka Pavlová, Lenka Radová, et al.. (2021). Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 138(25). 2670–2685. 24 indexed citations
7.
Navrkalová, Veronika, Karla Plevová, Karol Pál, et al.. (2021). LYmphoid NeXt-Generation Sequencing (LYNX) Panel. Journal of Molecular Diagnostics. 23(8). 959–974. 14 indexed citations
8.
Leroy, Bernard, Isabelle Martins, Johanna Sofia Margareta Mattsson, et al.. (2020). Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death and Differentiation. 28(5). 1477–1492. 22 indexed citations
9.
Pavlová, Šárka, et al.. (2019). PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells. Leukemia Research. 89. 106288–106288. 6 indexed citations
10.
Tom, Nikola, Jitka Malčíková, Šárka Pavlová, et al.. (2018). ToTem: a tool for variant calling pipeline optimization. BMC Bioinformatics. 19(1). 243–243. 1 indexed citations
11.
Pavlová, Šárka, et al.. (2016). Long-term survival in working-age patients after cerebrovascular accident. S S Korsakov Journal of Neurology and Psychiatry. 116(3. Vyp. 2). 36–36. 2 indexed citations
12.
Janovská, Pavlína, Karla Plevová, Markéta Kaucká, et al.. (2015). Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(2). 459–469. 52 indexed citations
13.
Malčíková, Jitka, Kateřina Staňo Kozubík, Boris Tichý, et al.. (2014). Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. Leukemia. 29(4). 877–885. 106 indexed citations
14.
Kaucká, Markéta, Karla Plevová, Šárka Pavlová, et al.. (2013). The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration. Cancer Research. 73(5). 1491–1501. 82 indexed citations
15.
Navrkalová, Veronika, Jana Kmínková, Jitka Malčíková, et al.. (2013). ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin. Haematologica. 98(7). 1124–1131. 26 indexed citations
16.
Plevová, Karla, Hana Skuhrová Francová, Yvona Brychtová, et al.. (2013). Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. Haematologica. 99(2). 329–338. 30 indexed citations
17.
Pavlová, Šárka, et al.. (2011). [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].. PubMed. 150(3). 161–8. 1 indexed citations
18.
Kaucká, Markéta, Pavel Krejčı́, Karla Plevová, et al.. (2011). Post‐translational modifications regulate signalling by Ror1. Acta Physiologica. 203(3). 351–362. 29 indexed citations
19.
Vávrová, J, Martina Řezáčová, Doris Vokurková, et al.. (2003). Gamma Irradiation Results in Phosphorylation of p53 at Serine-392 in Human T-Lymphocyte Leukaemia Cell Line MOLT-4. Folia Biologica. 49(5). 191–196. 6 indexed citations
20.
Šmardová, Jana, et al.. (2002). Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast. Pathology & Oncology Research. 8(4). 245–251. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Tavolaro Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Michela Frenquelli Breakdown of academic impact, for papers by Xiangao Huang Breakdown of academic impact, for papers by Kathleen J. Till Breakdown of academic impact, for papers by Larry Mansouri Breakdown of academic impact, for papers by Archito T. Tamayo Breakdown of academic impact, for papers by Charis E. Teh Breakdown of academic impact, for papers by Anna Dolnik Breakdown of academic impact, for papers by Frédéric Gilles
Rankless by CCL
2026